Hot flashes and night sweats: a cardiovascular signal of menopause
Read more
Your cart ( 0 )
SHIPPING
Calculated at checkout
TOTAL
£0.00 GBP
The Journal . Health & Wellness
For decades, hot flashes and night sweats (collectively known as vasomotor symptoms) were dismissed as temporary quality-of-life inconveniences. However, modern cardiovascular research tells a different story. Far from being isolated, hormonal symptoms, severe VMS are increasingly recognized as signals of underlying vascular dysfunction.
Large population studies now show that women who experience severe or early-onset hot flashes are more likely to exhibit changes in arterial health, including endothelial dysfunction and subclinical atherosclerosis. In other words, the symptoms you feel on the surface may reflect changes occurring deep within your blood vessels.
Understanding this connection allows women to reframe VMS not as something to “push through,” but as an opportunity to assess and protect long-term heart health.
Yes. Multiple large observational studies, including the landmark Study of Women's Health Across the Nation (SWAN), have demonstrated a clear association between vasomotor symptoms and vascular health.
Women who report severe hot flashes have been shown to:
These findings suggest that VMS are not merely driven by temperature dysregulation alone, but are linked to changes in vascular tone, nitric oxide signaling, and oxidative stress. Hot flashes may reflect reduced flexibility and responsiveness of the blood vessels themselves.
Not all vasomotor symptoms carry the same cardiovascular implications. Research indicates that when hot flashes begin is just as important as how severe they are.
Women who experience early-onset VMS (beginning in the late reproductive years or early perimenopause) appear to have a stronger association with subclinical atherosclerosis than women whose symptoms begin later in the menopause transition.
Early-onset symptoms may signal:
This helps explain why some women develop cardiovascular disease earlier than expected, even in the absence of traditional risk factors.
Vasomotor symptoms rarely occur in isolation. Instead, they often cluster with an adverse cardiometabolic profile that further increases cardiovascular risk.
A recent review by Carson and colleagues highlights that women with frequent hot flashes or night sweats are more likely to have:
Importantly, many of these changes emerge during perimenopause, well before overt cardiovascular disease develops. This reinforces the idea that VMS may serve as an early warning sign, highlighting the need for proactive cardiovascular assessment rather than symptom suppression alone.
While hormonal replacement therapy is often the gold-standard treatment for menopause-related symptoms, many women seek alternative therapies. There are a number of supplements, including more mild phytoestrogens, that can help alleviate some VMS.
Hot flashes are more than a menopause nuisance; they are a window into vascular health. Frequent or early-onset vasomotor symptoms have been linked to arterial stiffness, endothelial dysfunction, and cardiometabolic risk factors that predict future heart disease.
If you are experiencing persistent VMS, this is an important time to monitor cardiovascular biomarkers such as blood pressure, lipid levels, glucose regulation, and inflammatory markers. Addressing vascular and mitochondrial health early, through lifestyle strategies and targeted nutritional support, may help manage symptoms while also protecting long-term heart health.
Learn more about menopause and heart health here.
You inherit your mitochondrial DNA entirely from your mother. Discover how this tiny genetic inheritance influences cellular energy, healthy aging, and longevity.
Jul 16, 2026 |8 mins to read
Mitochondrial Health | Research & Insights
Learn what mitochondrial peptides like MOTS-c and BPC-157 are, how they compare to MitoQ® Mitoquinol, and what the current evidence shows.
Jul 7, 2026 |6 mins to read